Nanomedicine
Scope & Guideline
Pioneering Research for Tomorrow's Medical Solutions
Introduction
Aims and Scopes
- Nanoparticle-based drug delivery systems:
Research on various nanoparticle formulations designed for targeted and controlled drug delivery, enhancing therapeutic efficacy while minimizing side effects. - Theranostics:
Integration of therapeutic and diagnostic capabilities in nanomedicine, allowing for real-time monitoring of treatment responses and disease progression. - Nanotechnology in cancer treatment:
Exploration of nanomaterials that can be used for cancer therapy, including drug delivery, photothermal therapy, and immunotherapy. - Biocompatibility and toxicity studies:
Investigation of the biocompatibility and potential toxic effects of nanomaterials on biological systems, crucial for their clinical application. - Innovative formulations and synthesis methods:
Development of novel nanoparticles and nanocarriers, including lipid-based, polymeric, and metal nanoparticles, to improve drug solubility and stability. - Nanomedicine for infectious diseases:
Utilization of nanotechnology to enhance the efficacy of treatments against bacterial, viral, and fungal infections, including the development of vaccines. - Nanotechnology in regenerative medicine:
Application of nanomaterials in tissue engineering and regenerative therapies, focusing on enhancing healing and regeneration processes.
Trending and Emerging
- Personalized nanomedicine:
An increasing number of studies are focusing on tailoring nanomedicine approaches to individual patient profiles, enhancing treatment efficacy and safety. - Smart and stimuli-responsive nanocarriers:
Research on nanocarriers that respond to specific stimuli (e.g., pH, temperature, or light) to release drugs at targeted sites is gaining momentum, showcasing advanced delivery systems. - Nanomedicine for chronic diseases:
Emerging research is focusing on the application of nanotechnology in managing chronic diseases such as diabetes and cardiovascular conditions, reflecting a shift towards long-term health management. - Combination therapies using nanotechnology:
There is a growing trend in combining nanomedicine with other therapeutic modalities, such as immunotherapy and gene therapy, to enhance overall treatment outcomes. - Nanotechnology in vaccine development:
The COVID-19 pandemic has accelerated interest in nanotechnology's role in vaccine development, leading to innovative delivery systems and adjuvants. - Artificial intelligence in nanomedicine:
Integration of AI and machine learning in the design, synthesis, and application of nanomedicines is emerging as a significant theme, indicating a technological evolution in the field.
Declining or Waning
- Traditional small molecule therapies:
There is a noticeable decrease in studies focusing on conventional small molecule drugs as researchers shift towards more innovative nanomedicine approaches. - Basic mechanistic studies of nanoparticles:
Research that solely focuses on the fundamental mechanisms of nanoparticle interactions without clinical relevance is becoming less prevalent, as the field moves towards translational research. - In vivo studies in animal models:
Although still important, there is a growing preference for human-relevant models and clinical trials, leading to fewer publications centered on animal studies. - Nanoparticle applications in non-biomedical fields:
The focus on nanotechnology applications outside of direct medical contexts, such as environmental or industrial applications, is diminishing within the journal's scope.
Similar Journals
Beilstein Journal of Nanotechnology
Fostering interdisciplinary collaboration in nanotechnology.The Beilstein Journal of Nanotechnology is a prominent open access journal published by the Beilstein Institute that has been at the forefront of nanotechnology research since its inception in 2010. With a focus on cutting-edge developments in areas such as Electrical and Electronic Engineering, Materials Science, and Physics and Astronomy, this journal is ranked in the Q2 category across multiple scientific disciplines, reflecting its significant impact within the research community. The journal is accessible to a global audience and aims to foster innovation and application of nanotechnology across various fields. Featuring a rich convergence of interdisciplinary studies, the Beilstein Journal of Nanotechnology offers a platform for researchers to share their findings, thus advancing the frontiers of knowledge in this dynamic field. With publishers based in Frankfurt am Main, Germany, it continues to contribute to the scientific dialogue on nanoscience and its practical applications, making it an essential resource for academics, professionals, and students eager to stay at the cutting edge of technology.
Biomaterials Science
Advancing the future of healthcare through innovative biomaterials.Biomaterials Science is a premier journal published by the Royal Society of Chemistry that serves as a leading platform for researchers and professionals in the fields of Biomedical Engineering and Materials Science. With an impressive impact factor bolstered by its Q1 quartile ranking in both disciplines, this journal has positioned itself at the forefront of cutting-edge research, showcasing innovative materials and applications that drive advancements in healthcare and technology. Since its inception in 2013, Biomaterials Science has been committed to disseminating high-quality, peer-reviewed articles that promote scientific knowledge and collaboration among academia and industry. With a global readership and a focus on open access, researchers are encouraged to share their findings to facilitate the development of transformative biomaterials and their applications. Join a vibrant community of scholars as we explore the future of biomaterials through this esteemed publication, enhancing both scientific inquiry and practical application.
Cancer Nanotechnology
Exploring the Future of Cancer Therapies through NanotechnologyCancer Nanotechnology is a cutting-edge peer-reviewed journal dedicated to advancing the field of cancer research through innovative nanotechnology applications. Published by SPRINGER WIEN, this open-access journal, established in 2010, provides a vital platform for the dissemination of high-quality research with a focus on the intersection of nanotechnology, oncology, and biomedical engineering. With a commitment to promoting accessibility and fostering collaboration, Cancer Nanotechnology has gained impressive rankings within specialized categories, including Q2 in Biomedical Engineering and Pharmaceutical Science. The journal's rigorous selection process ensures that only the most impactful studies reach its audience, making it a must-read for researchers, professionals, and students eager to explore the latest advancements and methodologies in cancer treatment. With its scope encompassing critical topics that bridge multiple disciplines—including physical chemistry and toxicology—Cancer Nanotechnology positions itself as an influential resource for shaping the future of cancer therapies.
ACS Nano
Transforming Knowledge into Nanotechnology BreakthroughsACS Nano, published by the American Chemical Society, stands as a prestigious journal in the domains of Engineering, Materials Science, Nanoscience, and Physics. With an exceptional impact factor reflecting its standing as a Q1 category journal in multiple disciplines, it plays a pivotal role in disseminating groundbreaking research from 2007 to 2024. Known for its rigorous peer-review process, the journal boasts impressive Scopus rankings—positioned at #1 in General Engineering and #6 in General Physics and Astronomy—placing it among the top 1% of journals in its field. Although it is not an open-access publication, ACS Nano provides a wealth of knowledge that is essential for advancing the development of nanotechnology and its applications across various industries. Researchers, professionals, and students alike will find in its pages a trove of innovative studies and insights that drive the future of materials science and engineering.
Nanotechnology Reviews
Empowering Global Research in NanoscienceNanotechnology Reviews, published by DE GRUYTER POLAND SP Z O O, stands at the forefront of the multidisciplinary field of nanoscience and nanotechnology. With an Open Access model adopted since 2019, this journal, identifiable by its ISSN 2191-9089 and E-ISSN 2191-9097, disseminates vital research that is accessible to a global audience. The journal is located in Germany and has established itself as a premier platform for innovative research, boasting impressive quartile rankings: Q1 across several categories including Biotechnology, Energy Engineering, and Materials Science, as well as a Q2 classification in Biomaterials as of 2023. The diverse scope enables authors to contribute to a range of topics, from biomedical applications to energy solutions and advanced materials, making it essential reading for researchers, professionals, and students passionate about cutting-edge developments. Additionally, with Scopus rankings highlighting its value across various domains and robust percentiles, including 94 in Engineering (miscellaneous), 93 in Medicine (miscellaneous), and 88 in Biotechnology, Nanotechnology Reviews is an influential and respected journal that fosters scientific dialogue and innovation.
BIOMATERIALS
Driving Excellence in Biomaterials Research and ApplicationBIOMATERIALS, published by Elsevier Science Ltd, is a premier academic journal dedicated to the interdisciplinary field of biomaterials research. With an impressive impact factor, it ranks in the Q1 quartile across multiple categories including Bioengineering, Biomaterials, and Biophysics, showcasing its significance in advancing scientific knowledge. Established in 1980 and set to converge its discussions through 2025, this journal provides a critical platform for researchers and professionals to disseminate their findings on the development, application, and performance of biomaterials. The journal covers a wide range of topics, from the mechanics of materials to nanotechnology, and is highly regarded with top Scopus rankings in essential categories, including an exceptional position within the 99th percentile for Biophysics. Although not an open access journal, BIOMATERIALS remains vital for students and established researchers alike, ensuring accessibility to groundbreaking research in the field. Engage with cutting-edge studies that pave the way for innovative applications in medicine, engineering, and beyond.
Nanomedicine-Nanotechnology Biology and Medicine
Pioneering Research in Nanomedicine for a Healthier TomorrowNanomedicine-Nanotechnology Biology and Medicine is a leading journal published by Elsevier, dedicated to the exploration of innovative applications of nanotechnology in the fields of biology and medicine. With an ISSN of 1549-9634 and an E-ISSN of 1549-9642, this esteemed journal provides a platform for high-quality research, comprehensively covering areas including bioengineering, biomedical engineering, pharmaceutical science, and nanoscience. Notably, it holds a significant position in various categories with a Q2 ranking in multiple disciplines and a prestigious Q1 ranking in Pharmaceutical Science, emphasizing its impact within the scientific community. By facilitating access to cutting-edge studies and advancements, Nanomedicine-Nanotechnology Biology and Medicine serves as an essential resource for researchers, professionals, and students alike, contributing significantly to the ongoing development of nanomedicine and its pivotal role in improving healthcare outcomes. The journal operates without open access; however, it remains committed to disseminating valuable knowledge to a global audience.
BIOMEDICAL MICRODEVICES
Advancing Microdevice Research for Better HealthBIOMEDICAL MICRODEVICES is a leading journal published by Springer that focuses on the innovative field of microdevices within biomedical engineering. With an ISSN of 1387-2176 and an E-ISSN of 1572-8781, BIOMEDICAL MICRODEVICES offers a prestigious platform for researchers to disseminate their findings from 1998 to 2024, demonstrating a long-standing commitment to advancing knowledge in this critical area. The journal is recognized for its significant contributions, boasting a Q2 ranking in Biomedical Engineering and Nanoscience and Nanotechnology, and a Q3 rank in Molecular Biology. Renowned for its rigorous peer-review process, it is positioned within the top 30% of its field according to Scopus rankings, making it a valuable resource for researchers and practitioners alike. Though it operates under a subscription model, the emphasis on quality and relevance within its scope ensures that BIOMEDICAL MICRODEVICES remains a vital source of cutting-edge research that bridges engineering and biological systems, fostering innovation and collaboration in the pursuit of novel health solutions.
Current Nanoscience
Innovating the Future of NanotechnologyCurrent Nanoscience is a prominent journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of nanoscience through the dissemination of high-quality research and review articles. Since its inception in 2006, the journal has provided a platform for innovative studies across a variety of related disciplines, including bioengineering, biomedical engineering, biotechnology, and nanotechnology, reflecting its diverse scope and interdisciplinary nature. With a Q3 ranking in several categories such as Biomedical Engineering and Pharmaceutical Science and a Scopus percentile ranking around the 60th in its field, Current Nanoscience serves as a vital resource for researchers and professionals seeking to stay abreast of the latest developments and breakthroughs. Although it operates without an open access model, the journal maintains a commitment to enhancing accessibility and relevance in the scientific community. The editorial team is focused on publishing articles that address both theoretical and practical aspects of nanoscience, ensuring that the findings contribute to knowledge and innovation in areas critical to technology and healthcare.
VIEW
Transforming Ideas into Innovations in Biomaterials Science.VIEW is a prestigious journal published by WILEY that focuses on the rapidly evolving fields of Biomaterials and Biomedical Engineering. Since its inception in 2020, VIEW has established itself as an open-access platform dedicated to disseminating high-quality research and innovation within these disciplines. With an impressive impact factor that places it in the Q1 category of both Biomaterials and Biomedical Engineering, VIEW ranks among the top journals in its field, boasting a 91st percentile ranking in Biomedical Engineering and an 85th percentile ranking in Materials Science. Researchers, professionals, and students are encouraged to utilize this invaluable resource, as it provides a comprehensive view of current advancements and future trends in biomaterial science and engineering. Positioned in the United Kingdom, VIEW operates as a vital scholarly communication link, fostering collaboration and knowledge sharing within an ever-growing global community.